FDA
-
-
-
-
-
-
-
Simulations Plus Highlights Platform Innovation and Strategic Direction at 2026 Investor Day
-
-
-
-
-
-
-
Simulations Plus Supports New FDA Roadmap for Reducing Animal Testing in Preclinical Safety Studies
-
-
-
-
-
-
-
Simulations Plus (SLP) Optimizes Business Unit Structure to Support Future Growth Following Recent Strategic Acquisitions
-
-
-
-
-
-
-
Simulations Plus Releases GastroPlus® Version 9.9
-
-
-
-
-
-
-
Simulations Plus (SLP) Acquires Immunetrics
-
-
-
-
-
-
-
Simulations Plus (SLP), University of Florida Awarded New FDA Contract to Support Development and Regulatory Assessment of Inhaled Products
-
-
-
-
-
-
-
Simulations Plus Successfully Delivers FDA-Funded Project
-
334,268 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


